000			01515 a2200409 4500
005			20250515011710.0
264		0	_c20100830
008			201008s 0 0 eng d
022			_a1578-1852
040			_aNLM _beng _cNLM
100	1		_aLópez-Aldeguer, José
245	0	0	_aNew targets and new drugs in the treatment of HIV. _h[electronic resource]
260			_bEnfermedades infecciosas y microbiologia clinica _cJul 2005
300			_a25-40 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAnti-HIV Agents _xpharmacology
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Delivery Systems
650	0	4	_aDrug Design
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aDrugs, Investigational _xtherapeutic use
650	0	4	_aHIV Fusion Inhibitors _xpharmacology
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHIV Integrase Inhibitors _xpharmacology
650	0	4	_aHIV Protease Inhibitors _xpharmacology
650	0	4	_aHIV Reverse Transcriptase _xantagonists & inhibitors
650	0	4	_aHIV-1 _xdrug effects
650	0	4	_aHumans
650	0	4	_aReceptors, Virus _xdrug effects
650	0	4	_aReverse Transcriptase Inhibitors _xpharmacology
650	0	4	_aVirus Physiological Phenomena _xdrug effects
700	1		_aAguirrebengoa, Koldo
700	1		_aArribas, José Ramón
700	1		_aEsté, José A
700	1		_aKindelán, José María
773	0		_tEnfermedades infecciosas y microbiologia clinica _gvol. 23 Suppl 2 _gp. 25-40
999			_c15991734 _d15991734